A Phase I Study of Gemtuzumab Ozogamicin in Combination With a Myeloablative Conditioning (MAC) Regimen and alloSCT in Children With High-Risk CD33+ AML: A New Targeted Immunochemotherapy Conditioning Regimen (GO-BU/CY)
Autor: | D. George, Prakash Satwani, Mitchell S. Cairo, J. Le Gall, F. Dela Cruz, C. van de Ven, Erin Morris, Zhezhen Jin, Joseph Schwartz, L.A. Baxter-Lowe, James Garvin, Monica Bhatia |
---|---|
Jazyk: | angličtina |
Předmět: | |
Zdroj: | Biology of Blood and Marrow Transplantation. (2):S247 |
ISSN: | 1083-8791 |
DOI: | 10.1016/j.bbmt.2010.12.283 |
Databáze: | OpenAIRE |
Externí odkaz: |